Blog
New research spotlights efficient technique in opposition to COVID-19 variants: the E7 monoclonal antibody
01
Aug
Aug
In a latest research printed within the Science Advances Journal, a bunch of researchers developed potent monoclonal antibodies from a extreme acute respiratory syndrome coronavirus (SARS-CoV) survivor vaccinated with BNT162b2 that targets the receptor binding area (RBD) of human angiotensin-converting enzyme 2 (huACE2)-dependent sarbecovirus. Examine: Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies remoted from a BNT162b2-vaccinated […]